Piramal Pharma (NSE:PPLPHARMA) Other Income (Expense) : ₹2,077 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Other Income (Expense)?

Piramal Pharma's other income expense for the Piramal Pharma's pretax income for the three months ended in Mar. 2025 was ₹583 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₹2,077 Mil.

Piramal Pharma Other Income (Expense) Historical Data

The historical data trend for Piramal Pharma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Other Income (Expense) Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Other Income (Expense)

3,173.90

2,703.60

1,720.90

2,077.40

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Income (Expense)	Get a 7-Day Free Trial											79.00	419.40	783.70	291.80	582.50

Piramal Pharma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,077 Mil.

Piramal Pharma (NSE:PPLPHARMA) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Piramal Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Other Income (Expense)

Traded in Other Exchanges

543635:India

Address

Kamani Junction, LBS Marg, Ground Floor, Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramalpharma.com

Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.

Piramal Pharma Headlines

No Headlines